With a range of treatments available for presbyopia, the challenge for clinicians is to guide patients toward the most ...

Tenpoint Therapeutics submitted a new drug application to the FDA for Brimochol PF, an eye drop for presbyopia treatment, ...

New ISO standards categorize SVIOLs into multifocal, EDOF, and FVR IOLs, requiring rigorous clinical testing for ...

The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...

Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...

Monovision is the name given to the art and science of fitting contact lenses on a patient who has developed presbyopia.

Extended depth of focus contact lenses improved near to intermediate vision while maintaining far vision, leading to higher satisfaction in individuals with presbyopia, according to a study.

Presbyopia is a common eye condition which makes it more challenging to see nearby objects ...

Question: I recently wore a sleep mask that was a little tight and ever since, my vision has been a little blurry when ...

Brimochol PF, a combination of brimonidine and carbachol, was found to enhance depth of focus and visual acuity in clinical ...

LENZ Therapeutics is progressing rapidly with its LNZ100 for presbyopia, aiming for a 2025 U.S. launch in a market valued at ...

LENZ Therapeutics, Inc.’s LENZ share price has surged by 5.25%, which has investors questioning if this is right time to sell.